Please wait...
About This Project
An estimated 6 – 7 million people in Latin America and 300,000 U.S. citizens are infected with the protozoan parasite Trypanosoma cruzi that results in Chagas’ disease, a neglected tropical disease (NTD). Principally spread by the kissing bug (cover image), there exists an urgent need for development of new therapeutics to replace the outdated clinically used drugs, benznidazole and nifurtimox. Our research focuses on the discovery of novel antichagasic compounds for improved medicine.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Crowdcuring the Blues: People, Technology and Research Against Depression
Depression is not a choice, but we can choose to do something about it. Depression is a single label used...
Are endangered tigers in Nepal threatened by diseases from dogs and cats?
Through our wildlife health work in Nepal, we have seen sick tigers that show symptoms similar to canine...
How does Sprint Training Impact Blood Sugar and Inflammation?
Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...